Equities

Bristol-Myers Squibb Co

0R1F:LSE

Bristol-Myers Squibb Co

  • Price (USD)44.27
  • Today's Change-0.185 / -0.42%
  • Shares traded24.67k
  • 1 Year change-34.17%
  • Beta--
Data delayed at least 20 minutes, as of May 17 2024 19:10 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Bristol-Myers Squibb Co grew net income 26.84% 6.33bn to 8.03bn despite relatively flat revenue growth.
Gross margin75.94%
Net profit margin-13.47%
Operating margin-11.03%
Return on assets-6.35%
Return on equity-25.45%
Return on investment-8.27%
More ▼

Cash flow in USDView more

In 2023, Bristol-Myers Squibb Co increased its cash reserves by 23.53%, or 2.19bn. The company earned 13.86bn from its operations for a Cash Flow Margin of 30.80%. In addition the company used 2.30bn on investing activities and also paid 9.42bn in financing cash flows.
Cash flow per share1.81
Price/Cash flow per share23.94
Book value per share8.14
Tangible book value per share-18.75
More ▼

Balance sheet in USDView more

Bristol-Myers Squibb Co has a Debt to Total Capital ratio of 77.09%, a lower figure than the previous year's 110.22%.
Current ratio1.11
Quick ratio0.9947
Total debt/total equity3.38
Total debt/total capital0.7709
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)3.21%
Div growth rate (5 year)7.34%
Payout ratio (TTM)--
EPS growth(5 years)4.90
EPS (TTM) vs
TTM 1 year ago		-190.34
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.